Barely Significant
← all excerpts

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration.

PLoS One · 2026 · PMC12965571 · PMID 41790719

Europe PMCDOI
1
hedged sentence
0.0470
closest p · 0.9× alpha
0.0470
boldest claim

The sentences

marginally significantp = 0.047actually significant
Only the BCVA reduction from V1 to V2 was marginally significant (est.: −0.029; p = 0.047, Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.